Tsuyoshi Kobayashi

Associate professor

Hiroshima University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tsuyoshi Kobayashi is an Associate Professor at Hiroshima University in Japan. His research primarily focuses on hepatocellular carcinoma, with recent publications addressing topics such as the clinical significance of circulating tumor cells, novel prognostic biomarkers, and the evaluation of liver immune statuses. His work contributes valuable insights into the prognostic factors and treatment compliance associated with liver surgery and oncology.

Articles (25)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Woo-Hyoung Kang

Clinical assistant professor

Asan Medical Center

SOUTH KOREA

View details

Masateru Yamamoto

Hiroshima University

JAPAN

View details

Hiroyuki Tahara

Hiroshima University

JAPAN

View details

Kentaro Ide

Hiroshima University Hospital

JAPAN

View details

Hideki Ohdan

Professor

Hiroshima University

JAPAN

View details

Jongman Kim

Professor

Samsung Medical Center, Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Masataka Tsuge

Hiroshima University

JAPAN

View details

Yuki Imaoka

Assistant Professor

Hiroshima University

JAPAN

View details

Masaki Kaibori

Professor

Kansai Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tsuyoshi Kobayashi

Research Interests

Explore related searches

Contact this professor

About

Articles (25)

Clinical Significance of Circulating Tumor Cells in the Portal Vein of Patients with Hepatocellular Carcinoma Undergoing Anatomical Liver Resection

Response to Letter to the Editor Entitled “Clarifying Treatment Compliance and Future Directions in Perioperative Chemotherapy for Resectable Colorectal Liver Metastases”

FIB‐3 index as a novel age‐independent predictor of liver fibrosis and prognosis in hepatocellular carcinoma patients undergoing hepatectomy

Usefulness of preoperative peripheral blood GPC3‐positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort study

ASO Author Reflections: Albumin-Butyrylcholinesterase as a Novel Prognostic Biomarker for Hepatocellular Carcinoma Post-hepatectomy: A Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology

Albumin–Butyrylcholinesterase as a Novel Prognostic Biomarker for Hepatocellular Carcinoma Post-hepatectomy: A Retrospective Cohort Study with the Hiroshima Surgical Study Group of Clinical Oncology

Questionnaire on the surgical indications for intrahepatic cholangiocarcinoma administered to Japanese board‐certified expert hepatobiliary and pancreatic surgeons and instructors

The steatosis‐associated fibrosis estimator score is a useful indicator of recurrence and survival after initial curative hepatectomy for hepatocellular carcinoma

Feasibility, safety, and efficacy of intraoperative magnetic resonance imaging-guided hepatectomy for small hepatocellular carcinoma: A retrospective study

Impact of KIR-HLA Genotype on Natural-Killer-Cell-Based Immunotherapy for Preventing Hepatocellular Carcinoma after Living-Donor Liver Transplantation

Evaluation of prognostic efficacy of liver immune status index in predicting postoperative outcomes in hepatocellular carcinoma patients: A multi‐institutional retrospective study

Effect of genetic polymorphisms of interleukin‐1 beta on the microscopic portal vein invasion and prognosis of hepatocellular carcinoma

Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis

Comparison of postoperative outcomes in cases achieving sustained virological response with direct‐acting antiviral and interferon therapy

The efficacy and safety of pure laparoscopic liver resection for hepatocellular carcinoma in super‐elderly patients over 80 years: A multicenter propensity analysis

Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea–Japan collaborative study with 9200 patients

Association of Hepatobiliary Phase of Gadoxetic-Acid-Enhanced MRI Imaging with Immune Microenvironment and Response to Atezolizumab Plus Bevacizumab Treatment

Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma

Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study

Liver resection is associated with good outcomes for hepatocellular carcinoma patients beyond the Barcelona Clinic Liver Cancer criteria: A multicenter study with the Hiroshima Surgical study group of Clinical Oncology

National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan

Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy.

Induced pluripotent stem cell-derived, genetically engineered myeloid cells as unlimited cell source for dendritic cell-related cancer immunotherapy

PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resection, cohort study.

Impact of postoperative bile leakage on long-term outcome in patients following liver resection for hepatocellular carcinoma.

Collaborators (9)

Woo-Hyoung Kang

Masateru Yamamoto

Hiroyuki Tahara

Kentaro Ide

Hideki Ohdan

Jongman Kim

Masataka Tsuge

Yuki Imaoka

Masaki Kaibori

Make your next move.